Connect your AI

Pershing Square PS Accrued rebates

Accrued rebates at other companies

Kimberly-ClarkKMB

$195M-4.4%

Krystal Biotech, Inc.KRYS

$70.72M+49.2%

PACS GroupPACS

$181.13M+11.7%

Lantheus HoldingsLNTH

$69.88M—

SpireSR

$38.4M+19.3%

Indivior Pharmaceuticals, Inc. INDV

$551M-18.4%

Other financials

Income statement

Revenue$57.5M+9.9%

Operating income$5.1M-51.2%

Net income-$147.6M-848%

Balance sheet

Cash & equivalents$46.8M-95.0%

Total debt$91.2M—

Total equity$884.5M-7.0%

Total assets$990.5M—

Cash flow

Operating cash flow$87.9M+35.1%

Valuation

Market cap$13.33B—

Enterprise value$13.38B—

Returns & leverage

Debt / equity0.1×—

Where this comes from

Reported directly by Pershing Square in its filing.

Tagged under the XBRL concept us-gaap:AccruedExchangeFeeRebateCurrentAndNoncurrent.

The official record: Pershing Square ’s 10-Q, filed June 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pershing Square 's accrued rebates.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pershing Square 's accrued rebates?: Pershing Square (PS) reported accrued rebates of $0 in Q1 2026.